99mtc-nc100692
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2011 (NCT01230918)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc-nc100692
- 99mtc-nc100692
- technetium 99m nc100692
- technetium 99m nc 100692
- technetium 99m nc-100692
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01230918 | Phase 2 | May 1, 2011 | University of Ottawa |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Ottawa | Academic/Hospital | 1 | 1 | 1 | 2011 |
1 organizations
Page 1 / 1